NCT00022347 2013-06-26
TLK286 in Treating Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
National Cancer Institute (NCI)
Phase 2 Completed
Clinical Trials
13 trialsNCT00036920 2013-06-26
TLK286 in Treating Patients With Advanced Non-Small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT01148108 2013-03-15
Study of Canfosfamide in Refractory or Relapsed Mantle Cell, Diffuse Large B Cell Lymphoma and Multiple Myeloma
Telik
Phase 2 Completed
NCT00088556 2012-05-31
Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer
Telik
Phase 1/2 Completed
NCT00102973 2012-05-31
TLK286 (Telcyta) in Combination With Carboplatin (Paraplatin) Versus Doxil in Platinum Refractory or Resistant Ovarian Cancer
Telik
Phase 3 Completed
NCT00035841 2011-07-25
Phase 2 Study of TLK286 in Metastatic Breast Cancer
Telik
Phase 2 Completed
NCT00038428 2011-07-25
Phase 2 Study of TLK286 in Platinum Resistant Advanced Epithelial Ovarian Cancer
Telik
Phase 2 Completed
NCT00040638 2011-07-25
Phase 2 Study of TLK286 Administered Weekly in Advanced Non-Small Cell Lung Cancer
Telik
Phase 2 Completed
NCT00047801 2011-07-25
Phase 1-2a Dose-Ranging Study of TLK286 in Combination With Docetaxel in Platinum-Resistant Non-Small Cell Lung Cancer
Telik
Phase 1/2 Completed
NCT00051948 2011-07-25
TLK286 in Combination With Paraplatin (Carboplatin) in Recurrent Ovarian Cancer
Telik
Phase 1/2 Completed
NCT00052065 2011-07-25
TLK286 in Combination With Doxil in Platinum Refractory or Resistant Ovarian Cancer
Telik
Phase 1/2 Completed
NCT00077883 2011-07-25
TLK286 (Telcyta) in Combination With Cisplatin for Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)
Telik
Phase 1/2 Completed
NCT00080340 2008-01-15
Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Telik
Phase 3 Completed